Precigen IncNASDAQ:PGEN
- LAST PRICE1.4200
- TODAY'S CHANGE (%)0.0200 (1.4286%)
- Bid / Lots1.3900/ 33
- Ask / Lots1.4300/ 30
- Open / Previous Close1.4000 / 1.4000
- Day Range
- 52 Week Range
- Volume558,930
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PGEN |
|---|---|---|
| 09:32 ET | 1846 | 1.41 |
| 09:34 ET | 500 | 1.41 |
| 09:38 ET | 2300 | 1.41 |
| 09:39 ET | 400 | 1.405 |
| 09:41 ET | 2610 | 1.3983 |
| 09:43 ET | 2100 | 1.405 |
| 09:45 ET | 400 | 1.4 |
| 09:48 ET | 3825 | 1.395 |
| 09:50 ET | 683 | 1.4 |
| 09:52 ET | 200 | 1.4 |
| 09:56 ET | 1100 | 1.4 |
| 09:57 ET | 2180 | 1.4 |
| 09:59 ET | 200 | 1.4 |
| 10:01 ET | 3500 | 1.4 |
| 10:03 ET | 1425 | 1.4 |
| 10:06 ET | 4900 | 1.3934 |
| 10:08 ET | 767 | 1.3999 |
| 10:10 ET | 293 | 1.395 |
| 10:12 ET | 123 | 1.3994 |
| 10:15 ET | 200 | 1.4 |
| 10:17 ET | 396 | 1.4 |
| 10:19 ET | 1889 | 1.4 |
| 10:21 ET | 68903 | 1.4193 |
| 10:24 ET | 100 | 1.42 |
| 10:26 ET | 300 | 1.42 |
| 10:28 ET | 12122 | 1.415 |
| 10:30 ET | 6000 | 1.4 |
| 10:32 ET | 100 | 1.4 |
| 10:33 ET | 8798 | 1.4 |
| 10:35 ET | 2900 | 1.39 |
| 10:37 ET | 5444 | 1.3999 |
| 10:39 ET | 5600 | 1.395 |
| 10:42 ET | 4300 | 1.4 |
| 10:44 ET | 7700 | 1.395 |
| 10:46 ET | 17511 | 1.395 |
| 10:48 ET | 9898 | 1.395 |
| 10:50 ET | 5000 | 1.395 |
| 10:51 ET | 100 | 1.395 |
| 10:53 ET | 9691 | 1.395 |
| 10:55 ET | 2451 | 1.39 |
| 10:57 ET | 2989 | 1.39 |
| 11:00 ET | 300 | 1.395 |
| 11:02 ET | 600 | 1.39 |
| 11:04 ET | 8205 | 1.395 |
| 11:06 ET | 100 | 1.39 |
| 11:08 ET | 300 | 1.395 |
| 11:09 ET | 200 | 1.39 |
| 11:11 ET | 900 | 1.4 |
| 11:13 ET | 200 | 1.39 |
| 11:15 ET | 100 | 1.39 |
| 11:18 ET | 1128 | 1.395 |
| 11:20 ET | 200 | 1.4 |
| 11:22 ET | 428 | 1.4 |
| 11:24 ET | 300 | 1.4 |
| 11:26 ET | 700 | 1.395 |
| 11:27 ET | 400 | 1.4 |
| 11:29 ET | 11133 | 1.4 |
| 11:31 ET | 100 | 1.405 |
| 11:33 ET | 240 | 1.41 |
| 11:36 ET | 1000 | 1.4099 |
| 11:40 ET | 1000 | 1.405 |
| 11:42 ET | 300 | 1.405 |
| 11:44 ET | 4572 | 1.4 |
| 11:45 ET | 2617 | 1.4 |
| 11:47 ET | 1700 | 1.39 |
| 11:49 ET | 1981 | 1.3999 |
| 11:51 ET | 300 | 1.39 |
| 11:54 ET | 300 | 1.4 |
| 11:56 ET | 4271 | 1.4 |
| 11:58 ET | 200 | 1.4 |
| 12:00 ET | 3500 | 1.405 |
| 12:02 ET | 400 | 1.405 |
| 12:05 ET | 3651 | 1.4099 |
| 12:07 ET | 10300 | 1.4 |
| 12:09 ET | 300 | 1.4 |
| 12:12 ET | 10510 | 1.3999 |
| 12:16 ET | 4993 | 1.3999 |
| 12:18 ET | 7838 | 1.4 |
| 12:20 ET | 100 | 1.405 |
| 12:21 ET | 200 | 1.405 |
| 12:25 ET | 2500 | 1.405 |
| 12:27 ET | 6265 | 1.4 |
| 12:30 ET | 100 | 1.4 |
| 12:32 ET | 2250 | 1.4 |
| 12:34 ET | 200 | 1.4 |
| 12:38 ET | 200 | 1.4 |
| 12:39 ET | 1600 | 1.4 |
| 12:41 ET | 200 | 1.4 |
| 12:48 ET | 100 | 1.41 |
| 12:50 ET | 100 | 1.4 |
| 12:52 ET | 200 | 1.4 |
| 12:54 ET | 250 | 1.4009 |
| 12:56 ET | 200 | 1.4 |
| 12:57 ET | 5251 | 1.4 |
| 12:59 ET | 223 | 1.405 |
| 01:01 ET | 300 | 1.41 |
| 01:08 ET | 100 | 1.4 |
| 01:10 ET | 3696 | 1.4 |
| 01:12 ET | 599 | 1.4 |
| 01:14 ET | 100 | 1.405 |
| 01:15 ET | 100 | 1.41 |
| 01:17 ET | 300 | 1.4 |
| 01:19 ET | 114 | 1.4 |
| 01:26 ET | 100 | 1.4 |
| 01:28 ET | 100 | 1.4 |
| 01:30 ET | 400 | 1.4 |
| 01:35 ET | 100 | 1.41 |
| 01:37 ET | 599 | 1.4 |
| 01:39 ET | 200 | 1.4 |
| 01:42 ET | 200 | 1.4 |
| 01:46 ET | 100 | 1.405 |
| 01:48 ET | 14921 | 1.42 |
| 01:50 ET | 847 | 1.415 |
| 01:53 ET | 8068 | 1.42 |
| 01:55 ET | 400 | 1.42 |
| 01:57 ET | 300 | 1.425 |
| 02:00 ET | 100 | 1.43 |
| 02:02 ET | 100 | 1.42 |
| 02:04 ET | 500 | 1.42 |
| 02:06 ET | 16881 | 1.41 |
| 02:08 ET | 209 | 1.41 |
| 02:09 ET | 300 | 1.41 |
| 02:11 ET | 100 | 1.41 |
| 02:13 ET | 100 | 1.41 |
| 02:15 ET | 7092 | 1.4191 |
| 02:18 ET | 200 | 1.42 |
| 02:20 ET | 697 | 1.41 |
| 02:24 ET | 286 | 1.4147 |
| 02:26 ET | 200 | 1.41 |
| 02:27 ET | 100 | 1.41 |
| 02:29 ET | 100 | 1.415 |
| 02:31 ET | 800 | 1.41 |
| 02:33 ET | 13463 | 1.4 |
| 02:36 ET | 231 | 1.405 |
| 02:38 ET | 5100 | 1.4074 |
| 02:40 ET | 2100 | 1.4 |
| 02:42 ET | 100 | 1.405 |
| 02:44 ET | 300 | 1.405 |
| 02:45 ET | 100 | 1.4 |
| 02:47 ET | 100 | 1.405 |
| 02:49 ET | 300 | 1.41 |
| 02:51 ET | 100 | 1.4 |
| 02:54 ET | 200 | 1.4 |
| 02:56 ET | 100 | 1.41 |
| 02:58 ET | 200 | 1.4 |
| 03:00 ET | 100 | 1.4 |
| 03:02 ET | 500 | 1.4 |
| 03:05 ET | 740 | 1.402 |
| 03:07 ET | 500 | 1.4 |
| 03:09 ET | 400 | 1.4 |
| 03:12 ET | 500 | 1.405 |
| 03:14 ET | 400 | 1.4 |
| 03:16 ET | 600 | 1.4 |
| 03:18 ET | 500 | 1.4 |
| 03:20 ET | 700 | 1.405 |
| 03:21 ET | 100 | 1.4 |
| 03:23 ET | 200 | 1.4 |
| 03:25 ET | 300 | 1.4 |
| 03:27 ET | 400 | 1.4 |
| 03:30 ET | 100 | 1.4 |
| 03:34 ET | 100 | 1.4 |
| 03:36 ET | 645 | 1.4 |
| 03:38 ET | 400 | 1.4 |
| 03:39 ET | 100 | 1.4 |
| 03:41 ET | 100 | 1.4 |
| 03:43 ET | 300 | 1.405 |
| 03:45 ET | 300 | 1.4 |
| 03:48 ET | 12022 | 1.41 |
| 03:50 ET | 800 | 1.415 |
| 03:52 ET | 1500 | 1.415 |
| 03:54 ET | 13176 | 1.42 |
| 03:56 ET | 17861 | 1.425 |
| 03:57 ET | 3941 | 1.42 |
| 03:59 ET | 6756 | 1.42 |
Today
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesActym Therapeutics Appoints Thomas Smart as CEO, from 8 hours ago by Dow Jones
8 hours ago by Dow Jones
Mar 28, 2024
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Precigen Inc | 348.5M | -3.6x | --- |
Jasper Therapeutics Inc | 333.1M | -3.6x | --- |
Petro USA Inc | 320.2M | -10,000.0x | --- |
Verrica Pharmaceuticals Inc | 290.6M | -4.6x | --- |
Telomir Pharmaceuticals Inc | 172.3M | -14.5x | --- |
scPharmaceuticals Inc | 166.2M | -3.2x | --- |
Company Information
Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.
Contact Information
- Headquarters
- 20374 SENECA MEADOWS PARKWAYGERMANTOWN, MD, United States 20876
- Phone
- 301-556-9900
- Fax
- ---
Executives
- Executive Chairman of the Board
- Randal Kirk
- President, Chief Executive Officer, Director; President of PGEN Therapeutics, Inc.
- Helen Sabzevari
- Chief Financial Officer
- Harry Thomasian
- Chief Operating Officer
- Rutul Shah
- Senior Vice President - Intellectual Property Affairs
- Jeffrey Perez
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $348.5M |
|---|---|
Revenue (TTM) | $6.2M |
Shares Outstanding | 248.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-0.39 |
Book Value | $0.48 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | 56.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,601.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
